This company has been marked as potentially delisted and may not be actively trading. NASDAQ:XENT Intersect ENT (XENT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Intersect ENT Stock (NASDAQ:XENT) 30 days 90 days 365 days Advanced Chart Get Intersect ENT alerts:Sign Up Key Stats Today's Range$28.24▼$28.2450-Day Range$28.24▼$28.2452-Week Range$15.92▼$28.25Volume14,512 shsAverage Volume351,526 shsMarket Capitalization$954.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. The company offers PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to treat patients undergoing frontal sinus surgery; and PROPEL Contour, a steroid releasing implant for the treatment of frontal and maxillary sinus ostia, or openings, of the dependent sinuses. It also provides SINUVA, a steroid releasing implant for the treatment of patients in the physician office setting; VENSURE Navigable and Stand-alone balloon, a sterile and single-use device, used to access and treat frontal, sphenoid sinus, and maxillary ostia in adults using a trans-nasal approach; and CUBE Navigation System, a virtual guidance platform for high precision ENT and ENT related skull-base surgeries. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was incorporated in 2003 and is headquartered in Menlo Park, California. Read More Receive XENT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intersect ENT and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XENT Stock News HeadlinesKiatnakin Bank PCL (KKP)July 26, 2024 | investing.comXENT Historical DataOctober 21, 2023 | investing.comA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.September 15 at 2:00 AM | Investors Alley (Ad)Music At The Intersection Festival Tells St. Louis’ Rich Musical HistorySeptember 12, 2023 | yahoo.comCruise car reportedly swerves in backhoe's way, is busted in SF intersectionAugust 28, 2023 | sfgate.comWoman ejected from car after being hit by driver doing donuts in Long Beach intersectionJune 24, 2023 | cbsnews.comDrivers shut down Alexander County intersection during unsanctioned street takeoverFebruary 22, 2023 | news.yahoo.com4 levels of living space and a garage in D.C. Shaw’s neighborhoodFebruary 17, 2023 | washingtonpost.comSee More Headlines XENT Stock Analysis - Frequently Asked Questions How were Intersect ENT's earnings last quarter? Intersect ENT, Inc. (NASDAQ:XENT) posted its earnings results on Tuesday, November, 2nd. The medical equipment provider reported ($0.48) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by $0.06. The medical equipment provider had revenue of $24.40 million for the quarter, compared to the consensus estimate of $29.63 million. Intersect ENT had a negative trailing twelve-month return on equity of 709.52% and a negative net margin of 161.94%. What other stocks do shareholders of Intersect ENT own? Based on aggregate information from My MarketBeat watchlists, some other companies that Intersect ENT investors own include SEASPAN CORP/SH SH (SSW), Textainer Group (TGH), iShares MSCI Brazil ETF (EWZ), Costamare (CMRE), Mimecast (MIME), EOG Resources (EOG) and Air Transport Services Group (ATSG). Company Calendar Last Earnings11/02/2021Today9/15/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:XENT CIK1271214 Webwww.intersectent.com Phone(650) 641-2100Fax866-736-1251Employees433Year Founded2003Profitability EPS (Trailing Twelve Months)($4.79) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$159.63 million Net Margins-161.94% Pretax Margin-163.16% Return on Equity-709.52% Return on Assets-48.18% Debt Debt-to-Equity Ratio6.89 Current Ratio1.88 Quick Ratio1.50 Sales & Book Value Annual Sales$106.75 million Price / Sales8.95 Cash FlowN/A Price / Cash FlowN/A Book Value($2.06) per share Price / Book-13.71Miscellaneous Outstanding Shares33,814,000Free Float33,104,000Market Cap$954.91 million OptionableOptionable Beta1.45 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:XENT) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intersect ENT, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intersect ENT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
